Reynoutria multiflora (Thunb.) Moldenke and its ingredient suppress lethal prostate cancer growth by inducing CDC25B-CDK1 mediated cell cycle arrest.
PM, a traditional Chinese medicine, shows potential as a treatment for prostate cancer by suppressing cancer growth in an AR-dependent manner. This study investigates its anti-tumor mechanism in advanced prostate cancer.
- Zhou Q et al (2024).
- Bioorg Chem.
- PubMed:
- 39180863